Immune Oncology Research Institute
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
July 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jun
Immune Oncology Research Institute
Jul 23, 2024, 11:03 |
Insight
Karen Bedirian: Happy to be enrolled in the Principles and Practice of Clinical Research program at Harvard TH Chan School of Public Health
Karen Bedirian, Projects Director at Immune Oncology Research Institute, shared on LinkedIn: “Happy to be…
Jul 16, 2024, 20:14 |
Blog
Julia Hoveyan: Thrilled to present the state of pediatric neuro-oncology in Armenia at ISPNO 2024
Julia Hoveyan shared a post on LinkedIn: ''What a wonderful conference organized by the Children's…
Jul 15, 2024, 12:05 |
Blog
Ruzanna Papyan: Our abstract on Anti-GD2 for Neuroblastoma will be an oral presentation at SIOP
Ruzanna Papyan shared on LinkedIn: "Week 4 of the Global Access To Anti GD2 Campaign This…
Jul 13, 2024, 09:41 |
Insight
IMMONC - Immune Oncology Research Institute's Experience in Advancing Clinical Cancer Research in Armenia
Cancer affects people across the world regardless of their socioeconomic status. However, low- and middle-income…
Jul 5, 2024, 15:53 |
Drugs
Gevorg Tamamyan: Waiting to see promising bot/bal results from our lung cancer trial
Gevorg Tamamyan posted on LinkedIn: "Just saw the presentation from ESMO GI Annual Congress and the…
Jul 3, 2024, 23:36 |
Blog
Immune Oncology Research Institute - The BPDCN international registry continues to record successes
Immune Oncology Research Institute shared on LinkedIn: "The BPDCN international registry continues to record successes. Dr.…
Jul 1, 2024, 16:15 |
Blog
We need to hurry up, because cancer and patients cannot wait!
Gevorg Tamamyan, the Editor-in-chief of OncoDaily and CEO of Immune Oncology Research Institute, shared on…
Jun 21, 2024, 17:14 |
Blog
Amalya Sargsyan: Opening a new chapter in clinical trials for LMICs
Amalya Sargsyan shared a post on X: "Opening a new chapter in clinical trials for…
Jun 21, 2024, 01:37 |
Blog
ASCO's participants selected for the 2024 IDEA and IDEA-PC programs
American Society of Clinical Oncology (ASCO) shared a post on LinkedIn: "We congratulate the participants…
Jun 9, 2024, 08:12 |
Blog
Gevorg Tamamyan: The Yvonne Award received a warm welcome from the international professional community
Gevorg Tamamyan shared on LinkedIn: "Last Friday, on May 31, the OncoDaily Party and Yvonne Awards Ceremony…
May 30, 2024, 10:57 |
Insight
Julia Hoveyan: A year ago, the IMMONC launched the first-ever investigator-sponsored trial in pediatric oncology in Armenia
Ruzanna Papyan recently shared a post by Julia Hoveyan, Pediatric Oncologist at the Pediatric Cancer…
May 12, 2024, 07:56 |
Dialogues
OncoInfluencers: Dialogue with Fadlo R. Khuri, hosted by Gevorg Tamamyan
Join us for an exciting new episode of “OncoInfluencers”, hosted by Dr. Gevorg Tamamyan. In this episode, we…
May 7, 2024, 16:26 |
Blog
OncoDaily Leukemia Conference which took place on April 25-27 at Yeolyan Center - Pediatric Cancer and Blood Disorders Center of Armenia
Pediatric Cancer and Blood Disorders Center of Armenia shared a post on LinkedIn: "OncoDaily in…
Apr 23, 2024, 07:52 |
Dialogues
Oncothon: Pediatric Cancer Care Centralization In Netherlands and It's Outcomes
Oncothon is a telethon spanning 24 hours, dedicated to gathering donations for childhood cancer research.…
Apr 15, 2024, 04:04 |
Blog
Amalya Sargsyan: Proud to see IMMONC spotlighted in ASCO's latest policy statement on global equity in clinical trials
Amalya Sargsyan, Medical Oncologist at Yeolyan Hematology and Oncology Center, posted on LinkedIn: "Extremely proud to…
Apr 1, 2024, 18:54 |
Career
Hayk Grigoryan - elected as the next president of the Armenian Association of Hematology and Oncology
Gevorg Tamamyan shared on Facebook: "I am happy to announce that Hayk Grigoryan was elected…
Mar 13, 2024, 22:47 |
Blog
We invite you to join our mission to build international dataset and raise awareness about these rare diseases - Rare Embryonal Tumors of the CNS International Registry
Rare Embryonal Tumors of the CNS International Registry posted on LinkedIn: "It's been a year…
Feb 14, 2024, 13:40 |
Insight
Karen Bedirian: Happy to share that IMMONC received regulatory approval to conduct a trial of BAL+BOT among patients with metastatic non-small cell lung cancer
Karen Bedirian, Projects Director at Immune Oncology Research Institute, shared on LinkedIn: "Happy to share…
Jan 31, 2024, 18:33 |
Stories
I met my incredible mentor, Dr. Maria Babak, at Harvard Medical School, who has been instrumental in shaping my career - Jemma Arakelyan via The Babak Lab
The Babak Lab shared on their LinkedIn page: "My name is Jemma Arakelyan. I am…
Jan 21, 2024, 18:56 |
Career
Our first podcast episode is airing on streaming platforms - Advanced Oncology
Advanced Oncology shared on their LinkedIn page: "Our first podcast episode is airing on streaming…
Nov 5, 2023, 19:00 |
Blog
Tatevik Margaryan: It's International Stress and Mental Health Awareness week
Tatevik Margaryan, Project Manager at Immune Oncology Research Institute shared on LinkedIn: It's International Stress…
Oct 26, 2023, 18:11 |
Blog
Amalya Sargsyan: It was a privilege to be part of the Grant writing school at Milano Bicocca
Amalya Sargsyan and Shushan Hovsepyan, Research Fellows at Immune Oncology Research Institute, shared a post by…
Jun 13, 2023, 17:24 |
Insight
In 16 months, we have registered more cancer clinical trials in Armenia, than throughout all the years before that - Gevorg Tamamyan
Last year, on February 4th I was doing a presentation about the cancer clinical trials…
All:
23
Posts:
1 - 100
The largest philanthropic partnership in The V Foundation’s history - Dolphins Cancer Challenge
Glecirasib: A Promising Novel KRAS G12C Inhibitor in Clinical Development
How the Médecins Sans Frontières Journal Inspired a Lifetime of Humanitarian Service: Paul Spiegel
OncoDaily Party and Yvonne Award Photos - Part 1
Michael Douglas: The Untold Story of His Battle Against Cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube